MedTrace Logo

Long Term Follow up of Patients Who Were Treated With Extracorporeal Membrane Oxygenation for Pandemic Influenza A/H1N1 Induced Severe Respiratory Failure

NCT01763060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2013-11-21

No results posted yet for this study

Summary

Patients treated with Extracorporeal Membrane Oxygenation (ecmo) for severe respiratory or circulatory failure show severe long term disability due to impaired lung -, cerebral-, cognitive function and impaired quality of life. This study investigates the long term outcome of all patients who are still alive three years after ECMO treatment for severe respiratory failure during the H1N1 2009 pandemic at the Karolinska University Hospital.

Conditions

  • Long Term Outcome

Interventions

RADIATION

CT scan

BEHAVIORAL

Cognitive function

RADIATION

MRI

Sponsors & Collaborators

  • Karolinska Institutet

    collaborator OTHER

  • Uppsala University Hospital

    collaborator OTHER

  • Karolinska University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01763060 on ClinicalTrials.gov